Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05299892 · ClinicalTrials.gov registry record · NA
Optimizing Soft Speech Recognition in Children With Hearing Loss
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05299892 is a NA study that has completed, run by Sonova. The registered enrollment target is 36 participants.
The verdict
NCT05299892, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Overhearing is important for vocabulary learning and speech and language development in young children. However, contemporary hearing aids are generally unable to provide adequate access to low-level auditory inputs from multiple talkers at a distance to capitalize on overhearing. A recent investigation by Jace Wolfe and colleagues showed that, even when aided, children with hearing loss had significantly poorer speech recognition at 40, 50 and 60 dBA compared to children with normal hearing. Furthermore, they showed that increasing hearing aid gain for very low-level inputs produced a statistically significant improvement in syllable-final plural recognition and a non-significant trend toward better monosyllabic word recognition at very low presentation levels. Additional research is needed to document low-level speech recognition ability of children with hearing loss as well as the potential benefit or detriment of increasing hearing aid gain for low-level inputs. A novel hearing aid technology known as Soft Speech Enhancer has been shown improve low-level speech perception in adults with hearing loss; however, the effect of Speech Enhancer on speech recognition in children is not yet known and will be evaluated.
Interventions
- DEVICE Phonak Audeo P or Naida P hearing aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05299892
The ClinicalTrials.gov registry entry for NCT05299892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonova, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phonak Audeo P or Naida P hearing aid is the first listed.
NCT05299892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05299892 about?
NCT05299892 is a clinical study titled "Optimizing Soft Speech Recognition in Children With Hearing Loss". Overhearing is important for vocabulary learning and speech and language development in young children. However, contemporary hearing aids are generally unable to provide adequate access to low-level auditory inputs from multiple talkers at a distance to capitalize on overhearing. A recent investiga...
What is the current status of trial NCT05299892?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-21. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT05299892?
The interventions under investigation include: Phonak Audeo P or Naida P hearing aid (DEVICE).
Who is sponsoring clinical trial NCT05299892?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.